Australia is focused on enhancing its commercialisation capability through translation of its world-class research into products and services to impact people’s health and wellbeing1.
Israel is a leader in innovation (ranked #13 in the world2), commercialisation and entrepreneurship, and a priority market for the Victorian and Federal Governments to increase R&D partnerships, exports, trade and investment. Israel is home to over 335 VC firms3, 350 multinational R&D centres4, and has generated 60+ unicorns5 (start-ups valued at over US$1 billion) and 7000+ startups4.
Australia and Israel have over five decades of strong bilateral ties and synergistic research strengths for strategic R&D partnerships across multiple sectors, especially in medical technologies, clinical trials, biotechnology, biomedical engineering, and digital health. Together, they have co-authored 1,827 publications from 2010 to 2019 across 27 research fields6.
Israel is interested in partnering with Victorian/Australian researchers and companies to co-develop and co-manufacture disruptive products and services for the global market.
Join us to hear our panel of experts share their experience and insights on how to create partnerships and business opportunities with Israel.
1 Melbourne Biomedical Precinct | 2 Global Innovation Index 2020 | 3Ginsum | 4Deloitte | 5Globes | 6 Israel Liaison Office Parkville
- Date | AEDT: Wednesday 6 October 2021
- Time | AEDT: 4:30pm – 6:00pm Presentations and panel discussion | 6:00pm – 6:30pm Virtual networking
- Live stream: Zoom Meetings (videos + microphones enabled for all guests)
- Price: FREE
This event will provide an opportunity for attendees to engage directly with our speakers. We welcome you to stay on for virtual networking following the presentations and Q&A discussion.
Who is it for?
- Researchers, clinicians, business leaders and entrepreneurs in medical technologies, biotechnology, biomedical engineering, and digital health
- Angel, VC and private equity investors
What you will learn?
- Priority areas for collaborations in Israel
- Information about funding opportunities
- How to engage and partner with Israel
- How to join the Victorian Government Trade Mission to Israel in Feb 2022
- To obtain expert advice from the Israel Liaison Office | Parkville
- To receive in-market support in Victoria and Israel
- To network with investors, scientists, government officials, industry leaders, entrepreneurs
- Leon Kempler AM, Chairman Australia-Israel Chamber of Commerce – AICC
- Dr Antonio Castillo, Israel Liaison Officer, Victorian Government
- Libby O’Connor, Snr Trade Manager Health, MedTech & Pharma, Global Victoria
- Angela Luttick, Co-founder, Executive Director, 360Biolabs
- Simon Rabl, Sector Strategy Manager, Medical Technologies & Pharmaceutical. Program Manager Victoria-Israel R&D (VISTECH), Victoria-Jiangsu R&D (VIC-JS TECH), Innovation and Medical Research, DJPR Victorian Government
Opening and closing remarks
- Tim Dillon, Agent General to the United Kingdom, Commissioner to Europe and Israel, Victorian Government
- Ron Gerstenfeld, Minister-Counselor, Deputy Chief of Mission, Embassy of Israel Canberra
- Jeff Malone, CEO, BioMelbourne Network
- Dr Antonio Castillo, Israel Liaison Officer, Victorian Government
This event is presented in partnership with the State Government of Victoria.
Dr Antonio Castillo
Dr Antonio Castillo BEng MSc PhD is the inaugural Israel Liaison Officer of the Victorian Government based at the Melbourne Biomedical Precinct in Parkville. Dr Castillo is a Chilean-Australian biotechnology engineer and arrived in Melbourne in 2014 as a skilled migrant sponsored by the State of Victoria. He has more than 15 years of experience in technology innovation and research and has worked in industry and academia in Chile, Germany, Israel, the USA and Australia. Dr Castillo holds a PhD in Molecular Genetics from the Weizmann Institute, an MSc in Biotechnology from Ben-Gurion University, a Diploma in Aquaculture from The Hebrew University, and a BEng in Aquaculture from Universidad Andrés Bello, Chile.
Leon Kempler AM
Leon Kempler AM is involved in various business activities. His Honorary roles include: National Chairman of the Australia-Israel Chamber of Commerce; Director of Israel Innovation Institute; President of Museums Victoria (Melbourne Museum, Scienceworks, Immigration Museum, Exhibition Building); Chairman of Questacon, Advisory Council (National Science and Technology Centre, Canberra); Director of Wonderment Walk Victoria; Honorary Life Governor of the General Sir John Monash Foundation; Patron of the Haven Foundation.
Libby O’Connor is the Senior Trade Manager for Health, Medtech and Pharma in Global Victoria in the Department of Jobs Precincts and Regions responsible for supporting and facilitating Victorian life-science, healthcare and medtech companies to access trade opportunities globally. Libby has led over 30 trade missions to a range of jurisdictions include, the US, Europe, North Asia, Greater China, South East Asia, supporting companies both in market and more recently virtually through introductions and program support at a range of conferences. She has also supported a number of inbound activities successfully introducing a range of global corporate stakeholders to Victorian life science companies and showcasing Victoria extensive biotech capability.
Libby has supported a number of activities in Israel, including a trade mission to Israel in December 2018. The mission joined the BioForum Summit, Partnering for Clinical Research, in Tel Aviv. The mission also supported a series of site visits and business matching meetings around the Summit.
Simon Rabl has been a member of the Science, Technology and Innovation team with the Victorian Government since 2005 where he has been involved in developing Victoria’s innovation policies and managing programs including bilateral R&D programs with Israel and China, major medical research capital developments (expansion of the Walter and Eliza Hall Institute; Melbourne Brain Centre) and a joint neurotrauma research initiative with the Transport Accident Commission. Prior to joining DJPR, Simon was a research contract manager and Company Secretary for Neurosciences Victoria Ltd and Neurosciences Australia Ltd (2001-2005). Simon graduated from the University of Melbourne (BSc (Hons), 1987) and worked in research at the Monash Centre for Early Human Development before joining the Victorian public sector as a graduate recruit (1991). Simon’s public sector experience includes roles in innovation policy and programs, capital development. health and medical research, human resources and workforce planning.
Angela Luttick is a virologist with more than 20 years’ experience in the discovery, development and commercialisation of novel drugs. Well accustomed to leading multidisciplinary teams and experienced in the generation and integrity of key discovery-stage biological data required for the preparation of IND packages used in filing numerous FDA submissions. Angela is a co-founder and executive director at 360biolabs and leads business development and commercialisation strategies for the company.